Engineered for protective support, designed for daily practice
Xcell Amnio Matrix™ (XAM) is a next-generation lyophilized amniotic membrane allograft developed to protect wounds across a broad range of acute and chronic conditions. As part of New Horizon Medical Solutions’ advanced biologics portfolio, XAM combines barrier protection, structural support, and handling simplicity — making it a go-to option for modern wound care practices.
Sourced from the proprietary processing technologies originally developed by Precise Bioscience, XAM maintains the integrity of the extracellular matrix (ECM), providing a structurally strong biologic without requiring cryopreservation.
Q4280